Refine Search
(179)
(196)
(753)
(1689)

NEW Hemophilia: Epidemiology Forecast to 2028

  • $3,995
  • July 2019
Add to Basket Quick View Add to Saved List

Hemophilia is an X-linked hereditary bleeding disorder characterized by impaired blood coagulation as a result of deficiencies in the production or function of coagulation factor VIII (hemophilia A) or factor IX (hemophilia B) (Bolton-Maggs and...

NEW Hidradenitis Suppurativa (HS): Epidemiology Forecast to 2028

  • $3,995
  • July 2019
Add to Basket Quick View Add to Saved List

Hidradenitis Suppurativa (HS) is a long term, recurrent skin condition that causes painful lumps under the skin that form near the hair follicles where there are sweat glands (NHS, 2016; Mayo Clinic, 2018). HS is characterized by abscesses and ...

NEW Female Infertility: Epidemiology Forecast to 2028

  • $3,995
  • July 2019
Add to Basket Quick View Add to Saved List

Infertility generally refers to a difficulty in becoming pregnant after trying to conceive for one year, whereas impaired fecundity includes problems either in becoming pregnant or carrying a pregnancy to term (Chandra, Copen and Stephen, 2013)...

NEW Hidradenitis Suppurativa: Opportunity Analysis and Forecasts to 2028

  • $10,995
  • July 2019
Add to Basket Quick View Add to Saved List

Hidradenitis Suppurativa (HS) is a chronic, inflammatory, debilitating skin disease that is characterized by the recurrent development of painful nodules and abscesses that rupture. This leads to the formation of sinus tracts and scarring on th...

Digital Therapeutics and Their Impact on Healthcare

  • $7,995
  • June 2019
Add to Basket Quick View Add to Saved List

Due to increasing levels in healthcare spending combined with declining R&D returns, digital therapeutics (DTx) represent a new way of treatment in which digital systems are used as regulatory‐approved, to treat medical conditions as prescr...

Allergic Diseases: Pipeline Offers Novel Approaches to Treat Increasingly Prevalent Conditions, with Strong Presence of Cytokine Mediators Among First-in-Class Products

  • $6,995
  • June 2019
Add to Basket Quick View Add to Saved List

An allergy or allergic disease is a condition that arises from an adverse reaction to an exogenous antigen, a substance that invokes an immunological response. These conditions are extremely common. The number of people diagnosed with allergic ...

B-Cell Non-Hodgkin’s Lymphoma (NHL): Opportunity Analysis and Forecasts to 2027

  • $10,995
  • June 2019
Add to Basket Quick View Add to Saved List

Non-Hodgkin’s lymphoma (NHL) comprises a heterogeneous group of proliferative malignancies that arise in the B cells, T cells, or natural killer (NK) cells within the lymphoid tissue, such as the lymph nodes, bone marrow, thymus, and spleen. B-...

B-Cell Non-Hodgkin’s Lymphoma: Epidemiology Forecast to 2027

  • $3,995
  • June 2019
Add to Basket Quick View Add to Saved List

Non-Hodgkin’s lymphoma (NHL) refers to a group of cancers that develop in the lymphatic system. In NHL, the patient’s immune system is affected by the uncontrollable growth of malignant white blood cells, resulting in the body’s inability to fi...

Post-Traumatic Stress Disorder (PTSD): Opportunity Analysis and Forecasts to 2028

  • $10,995
  • June 2019
Add to Basket Quick View Add to Saved List

Post-traumatic stress disorder (PTSD) is a psychiatric disorder that can occur in people who have experienced or witnessed a traumatic event such as a natural disaster, a serious accident, a terrorist act, war/combat, rape, or other violent per...

Post-Traumatic Stress Disorder: Epidemiology Forecast to 2028

  • $3,995
  • June 2019
Add to Basket Quick View Add to Saved List

Post-Traumatic Stress Disorder (PTSD) is a psychiatric disorder that can occur in people who have experienced or witnessed a traumatic event such as a natural disaster, a serious accident, a terrorist act, war/combat, rape, or other violent per...

Systemic Lupus Erythematosus: Programs Targeting Cytokine and Growth Factor Signaling Dominate First-in-Class Pipeline

  • $6,995
  • June 2019
Add to Basket Quick View Add to Saved List

Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. While SLE can affect multiple major organ systems in the body, one of its most severe...

Spinal Muscular Atrophy (SMA): Opportunity Analysis and Forecasts to 2028

  • $10,995
  • June 2019
Add to Basket Quick View Add to Saved List

SMA is an area that is expected to witness strong growth in the future, primarily due to launch of pipeline products that are expected to gradually capture market share from Biogen’s Spinraza. Also, the launch of survival motor neuron (SMN)- in...

Spinal Muscular Atrophy: Epidemiology Forecast to 2028

  • $3,995
  • June 2019
Add to Basket Quick View Add to Saved List

Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease characterized by degeneration of alpha motor neurons in the spinal cord, resulting in progressive proximal muscle weakness and paralysis. The most common form of SMA ...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy

  • $1,995
  • June 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Italy”. The report is an essential source of information and analysis on the healthcare, regulator...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil

  • $1,995
  • June 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Brazil”. The report is an essential source of information and analysis on the healthcare, regulato...

Partnerships, Licensing, Investments and M&A Deals and Trends for April 2019 in Pharmaceuticals

  • $1,000
  • June 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for April 2019 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and ...

Partnerships, Licensing, Investments and M&A Deals and Trends for 2018 in Pharmaceuticals

  • $3,500
  • June 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for 2018 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financ...

Partnerships, Licensing, Investments and M&A Deals and Trends for March 2019 in Pharmaceuticals

  • $1,000
  • June 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for March 2019 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and ...

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2019

  • $1,500
  • June 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2019” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and finan...

Obesity: Gut Hormone Receptors Retain Commercial Prominence

  • $6,995
  • May 2019
Add to Basket Quick View Add to Saved List

Obesity is a chronic and potentially fatal disease. The most prevalent metabolic disorder affecting people today, obesity requires multidisciplinary continuing treatment. Despite the market’s clinical and regulatory challenges, the obesity pipe...

Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2019" provides an overview of Dysgeusia (Taste Disorders) clinical trials scenario. This report provides top line data relating to the ...

Dyskinesia Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Dyskinesia Global Clinical Trials Review, H1, 2019" provides an overview of Dyskinesia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyskinesia. Rep...

Dyslipidemia Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Dyslipidemia Global Clinical Trials Review, H1, 2019" provides an overview of Dyslipidemia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyslipidemi...

Dysmenorrhea Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Dysmenorrhea Global Clinical Trials Review, H1, 2019" provides an overview of Dysmenorrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Dysmenorrhe...

Dyspareunia Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Dyspareunia Global Clinical Trials Review, H1, 2019" provides an overview of Dyspareunia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyspareunia. ...

Dyspepsia Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Dyspepsia Global Clinical Trials Review, H1, 2019" provides an overview of Dyspepsia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyspepsia. Report...

Dysphagia Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Dysphagia Global Clinical Trials Review, H1, 2019" provides an overview of Dysphagia clinical trials scenario. This report provides top line data relating to the clinical trials on Dysphagia. Report...

Drug Overdose Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Drug Overdose Global Clinical Trials Review, H1, 2019" provides an overview of Drug Overdose clinical trials scenario. This report provides top line data relating to the clinical trials on Drug Over...

Dry (Atrophic) Macular Degeneration Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Dry (Atrophic) Macular Degeneration Global Clinical Trials Review, H1, 2019" provides an overview of Dry (Atrophic) Macular Degeneration clinical trials scenario. This report provides top line data ...

Duchenne Muscular Dystrophy Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Duchenne Muscular Dystrophy Global Clinical Trials Review, H1, 2019" provides an overview of Duchenne Muscular Dystrophy clinical trials scenario. This report provides top line data relating to the ...

Join our mailing list
Find out first about the latest reports and offers.
Report Catalogue

Strategic Insight Reports

Market Analysis Reports

Databooks